Epigenetic Drug Discovery Efforts Expanding, with Solid Cancers Now Being Targeted

By Shinya Sato Targets for epigenetic drug discovery are now expanding beyond the field of hematologic cancer. Drug makers worldwide are starting to develop epigenetic drugs for solid tumors as well. In the future, development could expand to include diseases...read more